Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio del 2004

El cáncer de mama es el tumor invasivo más frecuente en mujeres, con más de un millón de casos y cerca de 600000 muertes al año en todo el mundo , con tasas de incidencia más altas en países industrializados, como Estados Unidos, Australia y países de Europa Occidental, que pueden estar relacionadas...

Full description

Autores:: Pabón Romero, Juan Carlos
Villa Velásquez, Hooverman

Tipo de recurso:

Fecha de publicación:: 2006

Institución:: Universidad Autónoma de Bucaramanga - UNAB

Repositorio:: Repositorio UNAB

Idioma:: spa

id	UNAB2_acbd3dbedd4c5c8c40aaf25fdab88b9f
oai_identifier_str	oai:repository.unab.edu.co:20.500.12749/1861
network_acronym_str	UNAB2
network_name_str	Repositorio UNAB
repository_id_str
dc.title.spa.fl_str_mv	Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio del 2004
dc.title.translated.eng.fl_str_mv	Mammographic and ultrasound findings from 10,000 studies performed in the radiology service of La Foscal between January 1998 and June 2004
title	Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio del 2004
spellingShingle	Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio del 2004 Radiodiagnosis Mammography Medicine Radiology Diagnostic images Diagnostic imaging X-rays Investigations Analysis Tumor Industrialized countries Radiodiagnóstico Mamografía Medicina Radiología Imágenes diagnósticas Diagnóstico por imagen Radiografías Investigaciones Análisis Tumor Países industrializados
title_short	Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio del 2004
title_full	Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio del 2004
title_fullStr	Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio del 2004
title_full_unstemmed	Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio del 2004
title_sort	Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio del 2004
dc.creator.fl_str_mv	Pabón Romero, Juan Carlos Villa Velásquez, Hooverman
dc.contributor.advisor.spa.fl_str_mv	Jaramillo Botero, Natalia Mantilla Suárez, Juan Carlos Rey Serrano, Juan José
dc.contributor.author.spa.fl_str_mv	Pabón Romero, Juan Carlos Villa Velásquez, Hooverman
dc.contributor.cvlac.spa.fl_str_mv	Rey Serrano, Juan José [0000265306] Jaramillo Botero, Natalia [0001361289] Mantilla Suárez, Juan Carlos [0001482827]
dc.contributor.googlescholar.spa.fl_str_mv	Rey Serrano, Juan José [es&oi=ao]
dc.contributor.orcid.spa.fl_str_mv	Rey Serrano, Juan José [0000-0002-6946-2444] Jaramillo Botero, Natalia [0000-0002-0126-1013] Mantilla Suárez, Juan Carlos [0000-0003-0201-0598]
dc.contributor.scopus.spa.fl_str_mv	Rey Serrano, Juan José [54793298100]
dc.contributor.researchgate.none.fl_str_mv	Jaramillo Botero, Natalia [Natalia-Jaramillo-Botero-2187679037]
dc.subject.keywords.eng.fl_str_mv	Radiodiagnosis Mammography Medicine Radiology Diagnostic images Diagnostic imaging X-rays Investigations Analysis Tumor Industrialized countries
topic	Radiodiagnosis Mammography Medicine Radiology Diagnostic images Diagnostic imaging X-rays Investigations Analysis Tumor Industrialized countries Radiodiagnóstico Mamografía Medicina Radiología Imágenes diagnósticas Diagnóstico por imagen Radiografías Investigaciones Análisis Tumor Países industrializados
dc.subject.lemb.spa.fl_str_mv	Radiodiagnóstico Mamografía Medicina Radiología Imágenes diagnósticas Diagnóstico por imagen Radiografías Investigaciones Análisis
dc.subject.proposal.spa.fl_str_mv	Tumor Países industrializados
description	El cáncer de mama es el tumor invasivo más frecuente en mujeres, con más de un millón de casos y cerca de 600000 muertes al año en todo el mundo , con tasas de incidencia más altas en países industrializados, como Estados Unidos, Australia y países de Europa Occidental, que pueden estar relacionadas con mudanzas en los patrones reproductivos así como una mayor uso de la mamografía2 3 4 5 . La tasa de incidencia no es igual para todos los grupos raciales y étnicos, lo que refleja los diversos grados de desarrollo socioeconómico y características culturales . La mamografía es el único método de tamizaje que ha demostrado reducción en la tasa de mortalidad debida a cáncer de mama, y en la revisión de 8 estudios controlados randomizados de mamografía y 2 de autoexamen, realizada por Jatoi,se evidenció una reducción de 22% en la tasa de mortalidad por cáncer de mama en mujeres de 50 años de edad o más, durante 14 años de observación, y de 15% en mujeres entre 40 y 49 años de edad. La disminución en las tasas de mortalidad fue casi totalmente atribuible a la reducción de la distribución del tamaño de cánceres detectados a través de la mamografía de tamizaje8 . El propósito principal de la mamografía es detectar el cáncer precozmente, cuando es pequeño, con ganglios negativos y requiere un tratamiento menos intenso y tiene un mejor pronóstico.
publishDate	2006
dc.date.issued.none.fl_str_mv	2006
dc.date.accessioned.none.fl_str_mv	2020-06-26T20:07:18Z
dc.date.available.none.fl_str_mv	2020-06-26T20:07:18Z
dc.type.driver.none.fl_str_mv	info:eu-repo/semantics/masterThesis
dc.type.local.spa.fl_str_mv	Tesis
dc.type.redcol.none.fl_str_mv	http://purl.org/redcol/resource_type/TM
dc.identifier.uri.none.fl_str_mv	http://hdl.handle.net/20.500.12749/1861
dc.identifier.instname.spa.fl_str_mv	instname:Universidad Autónoma de Bucaramanga - UNAB
dc.identifier.reponame.spa.fl_str_mv	reponame:Repositorio Institucional UNAB
url	http://hdl.handle.net/20.500.12749/1861
identifier_str_mv	instname:Universidad Autónoma de Bucaramanga - UNAB reponame:Repositorio Institucional UNAB
dc.language.iso.spa.fl_str_mv	spa
language	spa
dc.relation.references.spa.fl_str_mv	Pabón Romero, Juan Carlos, Villa Velásquez, Hooverman, Mantilla Suárez, Juan Carlos (2006). Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio de 2004. Bucaramanga (Colombia) : Universidad Autónoma de Bucaramanga UNAB IARC, WHO. Breast cancer, in Stewart B, Kleihues P (eds). World Cancer Report. Lyon: IARC Press, 2003; 188–19. Armstrong B. Recent trends in breast-cancer incidence and mortality in relation to changes in possible risk factors. Int J Cancer. 1976;17(2):204-211. Flaws, J. A., Bush, T. L., Newschaffer, C. J., Chu, K. C., Tarone, R. E., Brawley, O. W. (2000). Racial Differences in Breast Cancer Mortality. Arch Fam Med 9: 412-413 Ries L, Eisner M, Kosary M. SEER Cancer Statistics Review, 1973-1999. Bethesda, MD: National Cancer Institute, 2002. Miller B, Feuer E, Hankey B. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 1993; 43: 27–41Cancer 1994; 74: 222–227. NCI Cancer Surveillance Monograph Series, Number 4. Bethesda (MD): nacional Cancer Institute, 2003. Jatoi I. Breast cancer screening. Am J Surg, 1999; 177(6):518-24). Farria DM, Monses B. Screening mammography practice Essentials. Radiol Clin N Am 42 (2004) 831-843 American College of Radiology. Breast imaging reporting and data system (BI-RADS). Reston, VA: American College of Radiology; 2003. Chu KC, Tarone RE, Kessler LG, Ries LAG, Hankey BF, Miller BA et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996; 88:1571-1579. Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 2003; 53(6):342-355. Hamilton BE, Sutton PD, Ventura SJ. Revised birth and fertility rates for the 1990s and new rates for Hispanic populations, 2000 and 2001: United States. Natl Vital Stat Rep 2003; 51(12):1-94. Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997; 145(6):536-545. Health, United States, 2002 With Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics, 2002. Schwartsmann G Journal of clinical oncology, vol 19, #18s (sept 15 supplement<9, 2001: pp 118s-124s. Carrascal E. Registro poblacional de cáncer de Cali. Universidad del Valle - Cali - Colombia, editor. 1995. Cali: Departamento de Patología -Facultad de Salud.Programa de Investigación de Cáncer de Cali. Registro poblacional de cáncer del área metropolitana de Bucaramanga 2000-2003 Proyecto de investigación Universidad Autónoma de Bucaramanga-Instituto Nacional de Cancerología. Miller AB, To T, Wall C. Canadian national breast screening study: 1: breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992;147:1459-76. Romero J, Burbano R, Angarita M. Recomendaciones actuales para el tamizaje de cáncer de seno según la evidencia medica. Rev Col Cirugía, 2003;18:51-59. Falkenberry S, Legare R. Risk factors for breast cancer. Obst and Gyn Clin of N Am; 2002:29: 159-172. Ahmedin Jemal, Taylor Murray, Elizabeth Ward, Alicia Samuels, Ram C. Tiwari, Asma Ghafoor, Eric J. Feuer and Michael J. Cancer Statistics, 2005 Thun CA Cancer J Clin 2005;55;10 30 George H Perkins and Lavinia P Middleton Breast cancer in men 2003;327;239-240 BMJ Bland KI, Menck HR, Scott-Conner CE, Morrow M, Winchester DJ, Winchester DP. The national cancer data base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998;83:1262-73. Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN, et al. Molecular markers in male breast carcinoma. Cancer 1998;83:1947-55. Scott-Conner CH, Jochimsen PR, Menck HR, Winchester DJ. Ann analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 1999;125:775-81. Shoker BS, Jarvis C, Sibson DR,Walker C, Sloane JP. Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 1999;188:237-44. Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, et al. Mutation analysis of BRCA 1 and BRCA 2 in a male breast cancer population. Am J Hum Genet 1997;60:313-9.m J Hum Genet 1997;60:313-9. Bland KI, Menck HR, Scott-Conner CE, Morrow M, Winchester DJ, Winchester DP. The national cancer data base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998;83:1262-73. Scott-Conner CH, Jochimsen PR, Menck HR, Winchester DJ. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 1999;125:775-81. Amir H, Makwaya CK, Moshiro C, Kwesigabo G. Carcinoma of the male breast: a sexually transmitted disease? East Afr Med J. 1996;73:187-90. Giordano SH; Buzdar AU and Hortobagyi GN. Breast Cancer in Men. Ann Intern Med. 2002;137:678-687. Thomas DB, Jimenez LM, McTiernan A, Rosenblatt K, Stalsberg H, Stemhagen A, et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol. 1992;135:734-48. Hultborn R, Hanson C, Ko¨pf I, Verbiene´ I, Warnhammar E, Weimarck A. Prevalence of Klinefelter’s syndrome in male breast cancer patients. Anticancer Res. 1997;17:4293-7. van Geel AN, van Slooten EA, Mavrunac M, Hart AA. A retrospective study of male breast cancer in Holland. Br J Surg. 1985;72:724-7. Landis SH, Murria T, Bolden S et al. Cancer statistics 1998. CA Cancer J Clin 1998;48:6-29. Ries LAG, Miller BA, Hankey BF et al (eds). SEER Cancer Statistics Review, 1973 1991:Tables and Graphs. NIH publication number 94 2789. Bethesda, MD, US Department of Health and Human Services, National Cancer Institute, 1994. Parkin DM, Whelan SL, Ferlay J, Storm H: Cancer Incidence in Five Continents Vol.VIII. International Agency for research on Cancer [IARC], Lyon, France, IARC Scientific Publication No. 155. 2002. Saxena S, Szabo CI, Chopin S, Barjhoux L, Sinilnikova O, Lenoir G,Goldgar DE, Bhatanagar D: BRCA1 and BRCA2 in Indian BreastCancer patients. Hum Mut 2002, 20:473-474. Becher H, Schmidt S and Chang-Claude J. Reproductive factors and familial predisposition for breast cancer by age 50 years. A case-control-family study for assesing main effects and possible gene-environment interaction. Int J Epidemiol 2003;32:38-48 Claus EB, Risch N, Thompson D. Autosomal dominant inheritance of early-onset breast cancer. Cancer 1994;73:643–651. Miki Y, Swensen J, Shattuck-Eidens D. et al. Strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66–71. Wooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378(21/28):789–792. Easton DF, Steele L, Fields P, et al: Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 1997;61:120–128. Verhoog L, Brekelmans C, Seynaeve C et al. Survival and tumor characteristics of breast cancer patients with germline mutations of BRCA1. Lancet 1998;351:316–321. Marcus J, Watson P, Page D et al. Hereditary breast cancer: Pathobiology, prognosis,and BRCA1 and BRCA2 linkage. Cancer 1996;77:697–709. Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131:961–72. Claus EB, Risch N, Thompson D. Autosomal dominant inheritance of early-onset breast cancer. Cancer 1994;73:643–651. Peto J. Genetic predisposition to cancer. In: Cairns J, Lyon JL, Skolnik M,editors. Cancer incidence in defined populations. Banbury Report No. 4. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1980. p. 203–13. Saxena S, Rekhi B, Bansal A, Bagga A, Ch and S Murthy N. Clinico-morphological patterns of breast cancer ncluding family history in a New Delhi hospital, India-A cross-sectional study World Journal of Surgical Oncology 2005, 3:67. Chen Y, Thompson W, Semenciw R,Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarker Prev. 1999;8:855-861. Healy E, Cook E, Orav E, Schnitt S, Connolly J, Harris J. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993;11:1545-1552. Bernstein JL, Laponski RH, Thakore SS, Doucette JT, Thompson WD. The descriptive epidemiology of second primary breast cancer. Epidemiology 2003;14:552-558. Ottman R, Pike MC, King MC, Henderson BE. Practical guide for stimating risk for familial breast cancer. Lancet. 1983;2(8349):556-558. Mandelson MT, Oestreicher N, Porter PL et al. Breast density as a predictor of mammographic detection: Comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000;92:1081–1087. Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K. Mammographic Breast Density and Family History of Breast Cancer. Journal of the National Cancer Institute, Vol. 95, No. 7, April 2, 2003. Love SM, Gelman RS, Silen W. Fibrocystic ‘‘disease’’ of the breast—a nondisease? N Engl J Med 1982;307:1010–1014. Page DL, Dupont WD, Jensen RA. Papillary apocrine change of the breast associated with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1996;5:29–32. Page DL, Vander Zwaag R, Rogers LW et al. Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 1978;61:1055–1063. Berg WA, Campassi CI, Ioffe OB. Cystic Lesions of the Breast: Sonographic-Pathologic Correlation. Radiology 2003; 227:183–191. Kelsey JL. Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993:15;36-47. MacMahon B. Reproduction and cancer of the breast. Cancer 1993;71:3185-3188. MacMahon B, Cole P Lin TM et al. Age at first birth and breast cancer risk. World Health. Janjan N X, Wilson JF, Gillin M, et al. Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. Cancer 1988;61:252-254. Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745-751. Lambe M, Hsich C-C, Trichopoulos D et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994;331:5–9. Wohlfahrt J, Melbye M. Age at any birth is associated with breast cancer risk. Epidemiology 2001;12:68–73. Chie WC, Hsieh C, Newcomb PA et al. Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 2000;151:715–722. Bernier MO, Plu-Bureau G, Bossard N. Breastfeeding and risk of breast cancer: A meta analisys of publuished studies. Hum Reprod Update 2000; 6: 374-386. Zheng T, Holford TR, Mayne ST et al. Lactation and breast cancer risk: A case control study in Connecticut. Br J Cancer 2001;84:1472-1476. Torgerson DJ, Bell-Syer SE: Hormone replacement therapy and prevention of nonvertebral fractures. JAMA 2001285:2891–2897. Grodstein F, Stampfer MJ, Colditz GA et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1769–1775. Beral V, Bull D, Doll R et al. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047–1059. Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: Data from the Nurses’ Health Study. Am J Epidemiol 2000;152: 950–964. Hofseth LJ, Raafat AM, Osuch JR et al. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 1999;84:4559–4565. Ross RK, Paganini-Hill A, Wan PC et al. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J Natl Cancer Inst 2000;92:328–332. Schairer C, Lubin J, Troisi R et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000;283:485–491. Psaty BM, Smith NL, Lemaitre RN et al. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women. JAMA 2001285:906–913. Spinler SA, Hilleman DE, Cheng JW et al. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother 2001;35:589–617. Silvera SA, Miller AB, Rohan TE. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study. Cancer Causes Control. 2005 Nov;16(9):1059-63. Muti P, Trevisan M, Micheli A et al. Alcohol consumption and total estradiol in premenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:189–191. Dorgan JF, Baer DJ, Albert PS et al. Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 2001;93:710–715. Lash TL, Aschengrau A. Alcohol drinking and risk of breast cancer. The Breast Journal 2000;6:396–399. Smith-Warner SA, Spiegelman D, Yaun SS et al. Alcohol and breast cancer in women: A pooled analysis of cohort studies. JAMA 1998;279:535–540. Couch FJ, Cerhan JR, Vierkant RA, et al: Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. Cancer Epidemiol Biomarkers Prev 10: 327–332, 2001. Lee IM, Rexrode KM, Cook NR et al. Physical activity and breast cancer risk: The Women’s Health Study (United States). Cancer Causes Control 2001;12:137–145. Matthews CE, Shu XO, Jin F et al. Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study. Br J Cancer 2001;84:994–1001. Clark RA. Principles of cancer screening. Cancer Control 1995;2:485-92. Clark RA, Reintgen DS. Principles of cancer screening. In: Reintgen DS, editors. Cancer screening. St Louis (MO): Mosby; 1996. 1-22. Eddy DM. Common screening tests. Philadelphia: American College of Physicians; 1991. Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002;359:881-4. Clark R. Principles of cancer screening. Radiol Clin N Am 42 (2004) 735-746. Moskowitz M. Screening is not diagnosis. Radiology 1979;133:265-8. American Cancer Society. Breast cancer facts & figures 2003-2004. Atlanta (GA) : American Cancer Society; 2004. Bassett LW, Hendrick RE, Bassford TL, Butler PF, Cater D, DeBor M, et al. Quality determinants of mammography. Rockville (MD): Agency for health Policy and research, Public Health Service, US department of Health and Human Services;1994. Clinical Practice Guideline #3. AHCPR Publication #95-0632. Shapiro S, Venet W, Strax P, Venet L, Roeser R. 10 to 14 years effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349-55. Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993;341:973-8. Roberts MM, Alexander FE, Anderson TJ, Chetty U, Donnan PT, Forrest P, et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 1990;335:241-6. Miller AB, To T, Wall C. Canadian national breast screening study: 1: breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992;147:1459-76. Miller AB, To T, Wall C. Canadian national breast screening study: 2: breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 1992;147:1477-88. Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA 1995;273:149-54. Chang HR, Cole B, Bland KI. Nonpalpable brest cancer in women aged 40-49 years: a surgeon’s view of benefits from screening mammography. Monogr Natl Cancer Inst 1997;22:145-9. Yokoe T, Iino Y, Maemura M, Takei H, Horiguchi J, Matsumoto H, et al. Efficacy of mammography for detecting early breast cancer in women Ander 50. Anticancer Res 1998;18:4709-12. Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34. Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-2. NCI statement on mammography screening. Office of Communications/Mass Media Branch. Bethesda, MD: National Institutes of Health; February 21, 2002. Lee CH. Screening mammography: proven benefit, continued controversy. Radiol Clin N Am 40 (2002) 395-497. Huynh PT, Jarolimek AM, Daye S. The false-negative mammogram. Radiographics 1998;18:1137-54 Moskowitz M. Breast cancer: age-specific growth rates and screening strategies. Radiology 1986;161:37-41. Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Wenstein MC, et al . Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995;15:369-90. Kopans DB, Moore RH, McCarthy KA, Hall DA, Hulka CA, Whitman GJ, et al. Positive predictive value of breast biopsy performed as a result de mammography: there is not abrup change at age 50 years. Radiology 1996;200:357-60. Sickles EA. Breast cancer screening outomes in women ages 40-49: clinical experience with service screening using modern mammography. Monogr Natl Cancer Inst 1997;22:99-104. Curpen BN, Sickles EA, Sollito RA, Ominsky SH, Galvin HB, Frankel SD. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old. AJR Am J Roentgenol 1995;164:1099-103. Heimann R, Bradley J, Hellman S. The benefits of mammography are not limited to women of ages older than 50 years. Cancer 1998;82:2221-6. Maibenco D, Dauod Y, Phillips E, Saxe A. Relationship betwen method of detection of breast cancer and stage of disease, method of treatment and survival in women aged 40-49 years. Am Surg 1999;65:1061-6. Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183.134 screening mammograms in Alburquerque, New Mexico. Radiology 1998;209:511-8. Ernster VA, Barclay J. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. Monogr Natl Cancer Inst 1997;22:151-6. Evans WP, Starr AL, Bennos ES. Comparison of the relative incidente of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age. Radiology 1997;204:489-91. Tabar L, Faberberg G, Day NE, Holmberg. What is the optimum inteval betwen mammographic screening examinations? an analysis based on the latest results of the Swedish two-country breast cancer screening trial. Br J Cancer 1987;55:547-51. Tabar L, Fagerberg G, Chen H-H, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. Cancer 1995;75:2507-17. Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276:33-8. Moss S.A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40.Trial Steering Group. J Med Screen 1999;6:144-148. http://www.saludcolombia.com/actual/htmlnormas/Res412_00.htm. Wild JJ, Neal D. The use of high frequency ultrasonic waves for detecting changes of texture in living tisúes. Lancet 1951;1:655-657. Romero J, Aguirre D. BI-RADS en el informe ecográfico. Rev Col Radiol 2003;14(1):1325-1332. American College of Radiology. Standard for the perfomance of the breast US examination. Reston VA. ACR 2002. Smith DN. Breast Ultrasound. Radiol Clin N Am 2001;39:485-497. 154. Metha TS. Current uses of ultrasound in the evaluation of the breast. Radiol Clin N Am 2003;41:841-856. Gordon PB. Ultrasound for breast cancer screening and staging. Radiol Clin N Am 2002;40:431-441. Baker JA, Kornguth PJ, Soo MS, Walsk R y Mengoni P. Sonography of solid breast lesions: observer variability of lesion description and assessment. Am J Roentgenol 1999;172:1621-1625. Bosh AM, Kessels AGH et al. Interexamination variation of whole breast ultrasound. Br J Radiol 2003;328-331. Ikeda DM. Ecografía mamaria. En: Los Requisitos. Radiología de la mama. Edición en español. Ikeda DM Ed Elsevier Mosby Madrid; 2005 pp. 131-160. Hilton SW, Leopold GR, Olson LK, Wilson SA. Real-time breast Sonography; application in 300 consecutive patients. Am J Roentgenol 1984;147:479-486. Ciatto S, Cariaggi P, Bulgaresi P. The value of routine cytologic examination of breast cyst fluids. Acta Cytol 1987;31:301-304. Berg WA. Breast Ultrasonography: Cystic lesions and probable benign findings. In Women´s Imaging: categorical course syllabus. Leesburg VA. American Roentgen Ray Society 2004;95-101. Venta LA. Management of complex breast cysts. Am J Roentgenol 1999; 173: 1331-1336. Kolb TM, Lichy J, Newhouse JH. Occult cancer in women with dense breasts: detection with screening US—diagnostic yield and tumor characteristics. Radiology 1998;207:191-199. Palmer JR, Rosemberg L, Rao RS et al. Induced and spontaneous abortion in relation to risk of breast cancer (United States). Cancer Causes Control 1997;8:841-849. Berg WA. Cystic lesions of the breast: Sonographic- Pathologic correlation. Radiology 2003; 227: 183-191. Velasquez MV. Manejo de las lesiones quísticas complejas de seno. (Conferencia). Curso de Imágenes de la mujer. Fundación Santafé de Bogotá COL. 2003. Berg WA. Can clusters of microcyst appropriately be followed? (abstr). Radiology 2002;224:1375-1379. Mercado CL, Harmele-Bena D, Sinbger C et al. Papillary lesions of the breast: evaluation with stereotactic direccional vacuum-assisted biopsy. Radiology 2001;221:650-655. Stavros AT, Thickman D, Rapp CL, Dennos MA, Parker SH, Sisney GA. Solid breast nodules: use of Sonography to distinguish between benign and malignant lesions. Radiology 1995;196:123-134. Liberman L, Menell JH. BIRADS. Radiol Clin N Am 2002;40:409-430. Sickles EA. Probable benign breast lesions: when should follow-up be recommended and what is the optimal follow-up protocol?. Radiology 1999;213:11-14. Rahbar G, Sie AC, Hansen GC, Prince JS, Melany ML, Reynolds HE et al. Benign versus malignant solid breast masses: US differentiation. Radiology 1999;213:889-894. Dennis MA, Parker SH, Klauss AJ, Stavros AT et al. Breast Biopsy Avoidance: The Value of Normal Mammograms and Normal Sonograms in the Setting of a Palpable Lump. Radiology 2001; 219:186–191. Vignal P, Meslet MR, Romeo JM, Feuilhade F. Sonographic morphology of infiltrating breast carcinoma J Ultrasound med 2002;21:531-538. Sickles EA, Herzog KA. Intramammary scar tissue: a mimic of the mammographic appearance of carcinoma. AJR 1980;135:349–352 Sickles EA, Herzog KA. Mammography of the post-surgical breast. AJR 1981 ;136:585–588 Homer MJ. Mammographic appearance of the breast after needle localization and biopsy. Breast 1985 ;2:26–31 Dershaw DD, Shank B, Reisinger S. Mammographic findings after breast cancer treatment with local excision and definitive irradiation. Radiology 1987 ;164:455–461 Brenner RJ, Pfaff JM. Mammographic features after conservation therapy for malignant breast disease: serial findings standardized by regression analysis. AJR 1996 ;167:171–178 Brenner RJ, Pfaff JM. Mammographic changes after excisional breast biopsy for benign disease. AJR 1996;167:1047–1052 Lamm RL, Jackman RJ. Mammographic abnormalities caused by percutaneus stereotactic biopsy of histologically benign lesions evident on follow –up mammograms. AJR 2000;174:753–756 McDonald S, Saslow D and. Alciati MH. Performance and Reporting of Clinical Breast Examination: A Review of the Literature. CA Cancer J Clin 2004;54;345-361 Stavros, A T. Breast Ultrasound, eds. Lippincott Williams & Wilkins, 2006: 1-15. World Cancer Report IARC. Stewart BW, Kleihues P, editors. 188-219. 2003 Pardo C, Murillo R, Piñeros M, Castro MA. Casos nuevos de cáncer en el Instituto Nacional de Cancerología, Colombia, 2002. Rev Colomb Cancerol 2003; 7(3):4-19.
dc.rights.uri.*.fl_str_mv	http://creativecommons.org/licenses/by-nc-nd/2.5/co/
dc.rights.local.spa.fl_str_mv	Abierto (Texto Completo)
dc.rights.accessrights.spa.fl_str_mv	info:eu-repo/semantics/openAccess http://purl.org/coar/access_right/c_abf2
dc.rights.creativecommons.*.fl_str_mv	Atribución-NoComercial-SinDerivadas 2.5 Colombia
rights_invalid_str_mv	http://creativecommons.org/licenses/by-nc-nd/2.5/co/ Abierto (Texto Completo) http://purl.org/coar/access_right/c_abf2 Atribución-NoComercial-SinDerivadas 2.5 Colombia
eu_rights_str_mv	openAccess
dc.format.mimetype.spa.fl_str_mv	application/pdf
dc.coverage.spa.fl_str_mv	Bucaramanga (Santander, Colombia)
dc.publisher.grantor.spa.fl_str_mv	Universidad Autónoma de Bucaramanga UNAB
dc.publisher.faculty.spa.fl_str_mv	Facultad Ciencias de la Salud
dc.publisher.program.spa.fl_str_mv	Especialización en Radiología e Imágenes Diagnósticas
institution	Universidad Autónoma de Bucaramanga - UNAB
bitstream.url.fl_str_mv	https://repository.unab.edu.co/bitstream/20.500.12749/1861/1/2006_Tesis_Pabon_Romero_Juan_Carlos.pdf https://repository.unab.edu.co/bitstream/20.500.12749/1861/2/2006_Tesis_Pabon_Romero_Juan_Carlos.pdf.jpg
bitstream.checksum.fl_str_mv	de4750fcaee21b0b8ebc134230a3bf4c e0d075329ee1440bfade9df35e738d05
bitstream.checksumAlgorithm.fl_str_mv	MD5 MD5
repository.name.fl_str_mv	Repositorio Institucional \| Universidad Autónoma de Bucaramanga - UNAB
repository.mail.fl_str_mv	repositorio@unab.edu.co
_version_	1814278180169580544
spelling	Jaramillo Botero, NataliaMantilla Suárez, Juan CarlosRey Serrano, Juan JoséPabón Romero, Juan CarlosVilla Velásquez, HoovermanRey Serrano, Juan José [0000265306]Jaramillo Botero, Natalia [0001361289]Mantilla Suárez, Juan Carlos [0001482827]Rey Serrano, Juan José [es&oi=ao]Rey Serrano, Juan José [0000-0002-6946-2444]Jaramillo Botero, Natalia [0000-0002-0126-1013]Mantilla Suárez, Juan Carlos [0000-0003-0201-0598]Rey Serrano, Juan José [54793298100]Jaramillo Botero, Natalia [Natalia-Jaramillo-Botero-2187679037]2020-06-26T20:07:18Z2020-06-26T20:07:18Z2006http://hdl.handle.net/20.500.12749/1861instname:Universidad Autónoma de Bucaramanga - UNABreponame:Repositorio Institucional UNABEl cáncer de mama es el tumor invasivo más frecuente en mujeres, con más de un millón de casos y cerca de 600000 muertes al año en todo el mundo , con tasas de incidencia más altas en países industrializados, como Estados Unidos, Australia y países de Europa Occidental, que pueden estar relacionadas con mudanzas en los patrones reproductivos así como una mayor uso de la mamografía2 3 4 5 . La tasa de incidencia no es igual para todos los grupos raciales y étnicos, lo que refleja los diversos grados de desarrollo socioeconómico y características culturales . La mamografía es el único método de tamizaje que ha demostrado reducción en la tasa de mortalidad debida a cáncer de mama, y en la revisión de 8 estudios controlados randomizados de mamografía y 2 de autoexamen, realizada por Jatoi,se evidenció una reducción de 22% en la tasa de mortalidad por cáncer de mama en mujeres de 50 años de edad o más, durante 14 años de observación, y de 15% en mujeres entre 40 y 49 años de edad. La disminución en las tasas de mortalidad fue casi totalmente atribuible a la reducción de la distribución del tamaño de cánceres detectados a través de la mamografía de tamizaje8 . El propósito principal de la mamografía es detectar el cáncer precozmente, cuando es pequeño, con ganglios negativos y requiere un tratamiento menos intenso y tiene un mejor pronóstico.1. Planteamiento del problema 2. Objetivos 3. Marco teórico a. Epidemiología i. Frecuencia ii. Factores de riesgo b. Tamizaje mamográfico c. Ecografía mamaria 4. Metodología a. Tipo de estudio b. Universo y muestra c. Métodos e instrumentos d. Técnicas y procedimientos 5. Resultados a. Análisis univariado b. Análisis bivariado 6. Discusión 7. Conclusiones 8. Recomendaciones 9. BibliografíaEspecializaciónBreast cancer is the most common invasive tumor in women, with more than one million cases and nearly 600,000 deaths a year worldwide1 , with fees higher incidence in industrialized countries, such as the United States, Australia and Western European countries, which may be related to changes in reproductive patterns as well as greater use of mammogram 2 3 4 5 . The incidence rate is not the same for all racial groups and ethnic, reflecting the varying degrees of socioeconomic development and Cultural characteristics . Mammography is the only screening method that has shown a reduction in mortality rate due to breast cancer, and in the review of 8 studies randomized controlled mammography and 2 self-examination, performed by Jatoi, a 22% reduction in the death rate from cancer of breastfeed in women 50 years of age or older, during 14 years of observation, and than 15% in women between 40 and 49 years of age. The decrease in the rates of mortality was almost entirely attributable to the reduction in the distribution of size of cancers detected through screening mammography . He The main purpose of mammography is to detect cancer early, whenis small, node-negative and requires less intense treatment andhas a better prognosis.application/pdfspahttp://creativecommons.org/licenses/by-nc-nd/2.5/co/Abierto (Texto Completo)info:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2Atribución-NoComercial-SinDerivadas 2.5 ColombiaHallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio del 2004Mammographic and ultrasound findings from 10,000 studies performed in the radiology service of La Foscal between January 1998 and June 2004Especialista en Radiología e Imágenes DiagnósticasBucaramanga (Santander, Colombia)Universidad Autónoma de Bucaramanga UNABFacultad Ciencias de la SaludEspecialización en Radiología e Imágenes Diagnósticasinfo:eu-repo/semantics/masterThesisTesishttp://purl.org/redcol/resource_type/TMRadiodiagnosisMammographyMedicineRadiologyDiagnostic imagesDiagnostic imagingX-raysInvestigationsAnalysisTumorIndustrialized countriesRadiodiagnósticoMamografíaMedicinaRadiologíaImágenes diagnósticasDiagnóstico por imagenRadiografíasInvestigacionesAnálisisTumorPaíses industrializadosPabón Romero, Juan Carlos, Villa Velásquez, Hooverman, Mantilla Suárez, Juan Carlos (2006). Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio de 2004. Bucaramanga (Colombia) : Universidad Autónoma de Bucaramanga UNABIARC, WHO. Breast cancer, in Stewart B, Kleihues P (eds). World Cancer Report. Lyon: IARC Press, 2003; 188–19.Armstrong B. Recent trends in breast-cancer incidence and mortality in relation to changes in possible risk factors. Int J Cancer. 1976;17(2):204-211.Flaws, J. A., Bush, T. L., Newschaffer, C. J., Chu, K. C., Tarone, R. E., Brawley, O. W. (2000). Racial Differences in Breast Cancer Mortality. Arch Fam Med 9: 412-413Ries L, Eisner M, Kosary M. SEER Cancer Statistics Review, 1973-1999. Bethesda, MD: National Cancer Institute, 2002.Miller B, Feuer E, Hankey B. Recent incidence trends for breast cancer in women and the relevance of early detection: an update. CA Cancer J Clin 1993; 43: 27–41Cancer 1994; 74: 222–227.NCI Cancer Surveillance Monograph Series, Number 4. Bethesda (MD): nacional Cancer Institute, 2003.Jatoi I. Breast cancer screening. Am J Surg, 1999; 177(6):518-24).Farria DM, Monses B. Screening mammography practice Essentials. Radiol Clin N Am 42 (2004) 831-843American College of Radiology. Breast imaging reporting and data system (BI-RADS). Reston, VA: American College of Radiology; 2003.Chu KC, Tarone RE, Kessler LG, Ries LAG, Hankey BF, Miller BA et al. Recent trends in U.S. breast cancer incidence, survival, and mortality rates. J Natl Cancer Inst 1996; 88:1571-1579.Ghafoor A, Jemal A, Ward E, Cokkinides V, Smith R, Thun M. Trends in breast cancer by race and ethnicity. CA Cancer J Clin 2003; 53(6):342-355.Hamilton BE, Sutton PD, Ventura SJ. Revised birth and fertility rates for the 1990s and new rates for Hispanic populations, 2000 and 2001: United States. Natl Vital Stat Rep 2003; 51(12):1-94.Brett KM, Madans JH. Use of postmenopausal hormone replacement therapy: estimates from a nationally representative cohort study. Am J Epidemiol 1997; 145(6):536-545.Health, United States, 2002 With Chartbook on Trends in the Health of Americans. Hyattsville, MD: National Center for Health Statistics, 2002.Schwartsmann G Journal of clinical oncology, vol 19, #18s (sept 15 supplement<9, 2001: pp 118s-124s.Carrascal E. Registro poblacional de cáncer de Cali. Universidad del Valle - Cali - Colombia, editor. 1995. Cali: Departamento de Patología -Facultad de Salud.Programa de Investigación de Cáncer de Cali.Registro poblacional de cáncer del área metropolitana de Bucaramanga 2000-2003 Proyecto de investigación Universidad Autónoma de Bucaramanga-Instituto Nacional de Cancerología.Miller AB, To T, Wall C. Canadian national breast screening study: 1: breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992;147:1459-76.Romero J, Burbano R, Angarita M. Recomendaciones actuales para el tamizaje de cáncer de seno según la evidencia medica. Rev Col Cirugía, 2003;18:51-59.Falkenberry S, Legare R. Risk factors for breast cancer. Obst and Gyn Clin of N Am; 2002:29: 159-172.Ahmedin Jemal, Taylor Murray, Elizabeth Ward, Alicia Samuels, Ram C. Tiwari, Asma Ghafoor, Eric J. Feuer and Michael J. Cancer Statistics, 2005 Thun CA Cancer J Clin 2005;55;10 30George H Perkins and Lavinia P Middleton Breast cancer in men 2003;327;239-240 BMJBland KI, Menck HR, Scott-Conner CE, Morrow M, Winchester DJ, Winchester DP. The national cancer data base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998;83:1262-73.Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN, et al. Molecular markers in male breast carcinoma. Cancer 1998;83:1947-55.Scott-Conner CH, Jochimsen PR, Menck HR, Winchester DJ. Ann analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 1999;125:775-81.Shoker BS, Jarvis C, Sibson DR,Walker C, Sloane JP. Oestrogen receptor expression in the normal and pre-cancerous breast. J Pathol 1999;188:237-44.Friedman LS, Gayther SA, Kurosaki T, Gordon D, Noble B, Casey G, et al. Mutation analysis of BRCA 1 and BRCA 2 in a male breast cancer population. Am J Hum Genet 1997;60:313-9.m J Hum Genet 1997;60:313-9.Bland KI, Menck HR, Scott-Conner CE, Morrow M, Winchester DJ, Winchester DP. The national cancer data base 10-year survey of breast carcinoma treatment at hospitals in the United States. Cancer 1998;83:1262-73.Scott-Conner CH, Jochimsen PR, Menck HR, Winchester DJ. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 1999;125:775-81.Amir H, Makwaya CK, Moshiro C, Kwesigabo G. Carcinoma of the male breast: a sexually transmitted disease? East Afr Med J. 1996;73:187-90.Giordano SH; Buzdar AU and Hortobagyi GN. Breast Cancer in Men. Ann Intern Med. 2002;137:678-687.Thomas DB, Jimenez LM, McTiernan A, Rosenblatt K, Stalsberg H, Stemhagen A, et al. Breast cancer in men: risk factors with hormonal implications. Am J Epidemiol. 1992;135:734-48.Hultborn R, Hanson C, Ko¨pf I, Verbiene´ I, Warnhammar E, Weimarck A. Prevalence of Klinefelter’s syndrome in male breast cancer patients. Anticancer Res. 1997;17:4293-7.van Geel AN, van Slooten EA, Mavrunac M, Hart AA. A retrospective study of male breast cancer in Holland. Br J Surg. 1985;72:724-7.Landis SH, Murria T, Bolden S et al. Cancer statistics 1998. CA Cancer J Clin 1998;48:6-29.Ries LAG, Miller BA, Hankey BF et al (eds). SEER Cancer Statistics Review, 1973 1991:Tables and Graphs. NIH publication number 94 2789. Bethesda, MD, US Department of Health and Human Services, National Cancer Institute, 1994.Parkin DM, Whelan SL, Ferlay J, Storm H: Cancer Incidence in Five Continents Vol.VIII. International Agency for research on Cancer [IARC], Lyon, France, IARC Scientific Publication No. 155. 2002.Saxena S, Szabo CI, Chopin S, Barjhoux L, Sinilnikova O, Lenoir G,Goldgar DE, Bhatanagar D: BRCA1 and BRCA2 in Indian BreastCancer patients. Hum Mut 2002, 20:473-474.Becher H, Schmidt S and Chang-Claude J. Reproductive factors and familial predisposition for breast cancer by age 50 years. A case-control-family study for assesing main effects and possible gene-environment interaction. Int J Epidemiol 2003;32:38-48Claus EB, Risch N, Thompson D. Autosomal dominant inheritance of early-onset breast cancer. Cancer 1994;73:643–651.Miki Y, Swensen J, Shattuck-Eidens D. et al. Strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994;266:66–71.Wooster R, Bignell G, Lancaster J et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378(21/28):789–792.Easton DF, Steele L, Fields P, et al: Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet 1997;61:120–128.Verhoog L, Brekelmans C, Seynaeve C et al. Survival and tumor characteristics of breast cancer patients with germline mutations of BRCA1. Lancet 1998;351:316–321.Marcus J, Watson P, Page D et al. Hereditary breast cancer: Pathobiology, prognosis,and BRCA1 and BRCA2 linkage. Cancer 1996;77:697–709.Claus EB, Risch NJ, Thompson WD. Age at onset as an indicator of familial risk of breast cancer. Am J Epidemiol 1990;131:961–72.Claus EB, Risch N, Thompson D. Autosomal dominant inheritance of early-onset breast cancer. Cancer 1994;73:643–651.Peto J. Genetic predisposition to cancer. In: Cairns J, Lyon JL, Skolnik M,editors. Cancer incidence in defined populations. Banbury Report No. 4. Cold Spring Harbor (NY): Cold Spring Harbor Laboratory Press; 1980. p. 203–13.Saxena S, Rekhi B, Bansal A, Bagga A, Ch and S Murthy N. Clinico-morphological patterns of breast cancer ncluding family history in a New Delhi hospital, India-A cross-sectional study World Journal of Surgical Oncology 2005, 3:67.Chen Y, Thompson W, Semenciw R,Mao Y. Epidemiology of contralateral breast cancer. Cancer Epidemiol Biomarker Prev. 1999;8:855-861.Healy E, Cook E, Orav E, Schnitt S, Connolly J, Harris J. Contralateral breast cancer: clinical characteristics and impact on prognosis. J Clin Oncol. 1993;11:1545-1552.Bernstein JL, Laponski RH, Thakore SS, Doucette JT, Thompson WD. The descriptive epidemiology of second primary breast cancer. Epidemiology 2003;14:552-558.Ottman R, Pike MC, King MC, Henderson BE. Practical guide for stimating risk for familial breast cancer. Lancet. 1983;2(8349):556-558.Mandelson MT, Oestreicher N, Porter PL et al. Breast density as a predictor of mammographic detection: Comparison of interval- and screen-detected cancers. J Natl Cancer Inst 2000;92:1081–1087.Ziv E, Shepherd J, Smith-Bindman R, Kerlikowske K. Mammographic Breast Density and Family History of Breast Cancer. Journal of the National Cancer Institute, Vol. 95, No. 7, April 2, 2003.Love SM, Gelman RS, Silen W. Fibrocystic ‘‘disease’’ of the breast—a nondisease? N Engl J Med 1982;307:1010–1014.Page DL, Dupont WD, Jensen RA. Papillary apocrine change of the breast associated with atypical hyperplasia and risk of breast cancer. Cancer Epidemiol Biomarkers Prev 1996;5:29–32.Page DL, Vander Zwaag R, Rogers LW et al. Relation between component parts of fibrocystic disease complex and breast cancer. J Natl Cancer Inst 1978;61:1055–1063.Berg WA, Campassi CI, Ioffe OB. Cystic Lesions of the Breast: Sonographic-Pathologic Correlation. Radiology 2003; 227:183–191.Kelsey JL. Gammon MD, John EM. Reproductive factors and breast cancer. Epidemiol Rev 1993:15;36-47.MacMahon B. Reproduction and cancer of the breast. Cancer 1993;71:3185-3188.MacMahon B, Cole P Lin TM et al. Age at first birth and breast cancer risk. World Health.Janjan N X, Wilson JF, Gillin M, et al. Mammary carcinoma developing after radiotherapy and chemotherapy for Hodgkin's disease. Cancer 1988;61:252-254.Bhatia S, Robison LL, Oberlin O, et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med 1996;334:745-751.Lambe M, Hsich C-C, Trichopoulos D et al. Transient increase in the risk of breast cancer after giving birth. N Engl J Med 1994;331:5–9.Wohlfahrt J, Melbye M. Age at any birth is associated with breast cancer risk. Epidemiology 2001;12:68–73.Chie WC, Hsieh C, Newcomb PA et al. Age at any full-term pregnancy and breast cancer risk. Am J Epidemiol 2000;151:715–722.Bernier MO, Plu-Bureau G, Bossard N. Breastfeeding and risk of breast cancer: A meta analisys of publuished studies. Hum Reprod Update 2000; 6: 374-386.Zheng T, Holford TR, Mayne ST et al. Lactation and breast cancer risk: A case control study in Connecticut. Br J Cancer 2001;84:1472-1476.Torgerson DJ, Bell-Syer SE: Hormone replacement therapy and prevention of nonvertebral fractures. JAMA 2001285:2891–2897.Grodstein F, Stampfer MJ, Colditz GA et al. Postmenopausal hormone therapy and mortality. N Engl J Med 1997;336:1769–1775.Beral V, Bull D, Doll R et al. Breast cancer and hormone replacement therapy: Collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet 1997;350:1047–1059.Colditz GA, Rosner B. Cumulative risk of breast cancer to age 70 years according to risk factor status: Data from the Nurses’ Health Study. Am J Epidemiol 2000;152: 950–964.Hofseth LJ, Raafat AM, Osuch JR et al. Hormone replacement therapy with estrogen or estrogen plus medroxyprogesterone acetate is associated with increased epithelial proliferation in the normal postmenopausal breast. J Clin Endocrinol Metab 1999;84:4559–4565.Ross RK, Paganini-Hill A, Wan PC et al. Effect of hormone replacement therapy on breast cancer risk: Estrogen versus estrogen plus progestin. J Natl Cancer Inst 2000;92:328–332.Schairer C, Lubin J, Troisi R et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA 2000;283:485–491.Psaty BM, Smith NL, Lemaitre RN et al. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women. JAMA 2001285:906–913.Spinler SA, Hilleman DE, Cheng JW et al. New recommendations from the 1999 American College of Cardiology/American Heart Association acute myocardial infarction guidelines. Ann Pharmacother 2001;35:589–617.Silvera SA, Miller AB, Rohan TE. Oral contraceptive use and risk of breast cancer among women with a family history of breast cancer: a prospective cohort study. Cancer Causes Control. 2005 Nov;16(9):1059-63.Muti P, Trevisan M, Micheli A et al. Alcohol consumption and total estradiol in premenopausal women. Cancer Epidemiol Biomarkers Prev 1998;7:189–191.Dorgan JF, Baer DJ, Albert PS et al. Serum hormones and the alcohol-breast cancer association in postmenopausal women. J Natl Cancer Inst 2001;93:710–715.Lash TL, Aschengrau A. Alcohol drinking and risk of breast cancer. The Breast Journal 2000;6:396–399.Smith-Warner SA, Spiegelman D, Yaun SS et al. Alcohol and breast cancer in women: A pooled analysis of cohort studies. JAMA 1998;279:535–540.Couch FJ, Cerhan JR, Vierkant RA, et al: Cigarette smoking increases risk for breast cancer in high-risk breast cancer families. Cancer Epidemiol Biomarkers Prev 10: 327–332, 2001.Lee IM, Rexrode KM, Cook NR et al. Physical activity and breast cancer risk: The Women’s Health Study (United States). Cancer Causes Control 2001;12:137–145.Matthews CE, Shu XO, Jin F et al. Lifetime physical activity and breast cancer risk in the Shanghai Breast Cancer Study. Br J Cancer 2001;84:994–1001.Clark RA. Principles of cancer screening. Cancer Control 1995;2:485-92.Clark RA, Reintgen DS. Principles of cancer screening. In: Reintgen DS, editors. Cancer screening. St Louis (MO): Mosby; 1996. 1-22.Eddy DM. Common screening tests. Philadelphia: American College of Physicians; 1991.Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet 2002;359:881-4.Clark R. Principles of cancer screening. Radiol Clin N Am 42 (2004) 735-746.Moskowitz M. Screening is not diagnosis. Radiology 1979;133:265-8.American Cancer Society. Breast cancer facts & figures 2003-2004. Atlanta (GA) : American Cancer Society; 2004.Bassett LW, Hendrick RE, Bassford TL, Butler PF, Cater D, DeBor M, et al. Quality determinants of mammography. Rockville (MD): Agency for health Policy and research, Public Health Service, US department of Health and Human Services;1994. Clinical Practice Guideline #3. AHCPR Publication #95-0632.Shapiro S, Venet W, Strax P, Venet L, Roeser R. 10 to 14 years effect of screening on breast cancer mortality. J Natl Cancer Inst 1982;69:349-55.Nystrom L, Rutqvist LE, Wall S, Lindgren A, Lindqvist M, Ryden S, et al. Breast cancer screening with mammography: overview of Swedish randomized trials. Lancet 1993;341:973-8.Roberts MM, Alexander FE, Anderson TJ, Chetty U, Donnan PT, Forrest P, et al. Edinburgh trial of screening for breast cancer: mortality at seven years. Lancet 1990;335:241-6.Miller AB, To T, Wall C. Canadian national breast screening study: 1: breast cancer detection and death rates among women aged 40 to 49 years. Can Med Assoc J 1992;147:1459-76.Miller AB, To T, Wall C. Canadian national breast screening study: 2: breast cancer detection and death rates among women aged 50 to 59 years. Can Med Assoc J 1992;147:1477-88.Kerlikowske K, Grady D, Rubin SM, Sandrock C, Ernster VL. Efficacy of screening mammography: a meta-analysis. JAMA 1995;273:149-54.Chang HR, Cole B, Bland KI. Nonpalpable brest cancer in women aged 40-49 years: a surgeon’s view of benefits from screening mammography. Monogr Natl Cancer Inst 1997;22:145-9.Yokoe T, Iino Y, Maemura M, Takei H, Horiguchi J, Matsumoto H, et al. Efficacy of mammography for detecting early breast cancer in women Ander 50. Anticancer Res 1998;18:4709-12.Gotzsche PC, Olsen O. Is screening for breast cancer with mammography justifiable? Lancet 2000;355:129-34.Olsen O, Gotzsche PC. Cochrane review on screening for breast cancer with mammography. Lancet 2001;358:1340-2.NCI statement on mammography screening. Office of Communications/Mass Media Branch. Bethesda, MD: National Institutes of Health; February 21, 2002.Lee CH. Screening mammography: proven benefit, continued controversy. Radiol Clin N Am 40 (2002) 395-497.Huynh PT, Jarolimek AM, Daye S. The false-negative mammogram. Radiographics 1998;18:1137-54Moskowitz M. Breast cancer: age-specific growth rates and screening strategies. Radiology 1986;161:37-41.Tengs TO, Adams ME, Pliskin JS, Safran DG, Siegel JE, Wenstein MC, et al . Five-hundred life-saving interventions and their cost-effectiveness. Risk Anal 1995;15:369-90.Kopans DB, Moore RH, McCarthy KA, Hall DA, Hulka CA, Whitman GJ, et al. Positive predictive value of breast biopsy performed as a result de mammography: there is not abrup change at age 50 years. Radiology 1996;200:357-60.Sickles EA. Breast cancer screening outomes in women ages 40-49: clinical experience with service screening using modern mammography. Monogr Natl Cancer Inst 1997;22:99-104.Curpen BN, Sickles EA, Sollito RA, Ominsky SH, Galvin HB, Frankel SD. The comparative value of mammographic screening for women 40-49 years old versus women 50-64 years old. AJR Am J Roentgenol 1995;164:1099-103.Heimann R, Bradley J, Hellman S. The benefits of mammography are not limited to women of ages older than 50 years. Cancer 1998;82:2221-6.Maibenco D, Dauod Y, Phillips E, Saxe A. Relationship betwen method of detection of breast cancer and stage of disease, method of treatment and survival in women aged 40-49 years. Am Surg 1999;65:1061-6.Rosenberg RD, Hunt WC, Williamson MR, Gilliland FD, Wiest PW, Kelsey CA, et al. Effects of age, breast density, ethnicity, and estrogen replacement therapy on screening mammographic sensitivity and cancer stage at diagnosis: review of 183.134 screening mammograms in Alburquerque, New Mexico. Radiology 1998;209:511-8.Ernster VA, Barclay J. Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma. Monogr Natl Cancer Inst 1997;22:151-6.Evans WP, Starr AL, Bennos ES. Comparison of the relative incidente of impalpable invasive breast carcinoma and ductal carcinoma in situ in cancers detected in patients older and younger than 50 years of age. Radiology 1997;204:489-91.Tabar L, Faberberg G, Day NE, Holmberg. What is the optimum inteval betwen mammographic screening examinations? an analysis based on the latest results of the Swedish two-country breast cancer screening trial. Br J Cancer 1987;55:547-51.Tabar L, Fagerberg G, Chen H-H, Duffy SW, Smart CR, Gad A, et al. Efficacy of breast cancer screening by age. Cancer 1995;75:2507-17.Kerlikowske K, Grady D, Barclay J, Sickles EA, Ernster V. Effect of age, breast density, and family history on the sensitivity of first screening mammography. JAMA 1996;276:33-8.Moss S.A trial to study the effect on breast cancer mortality of annual mammographic screening in women starting at age 40.Trial Steering Group. J Med Screen 1999;6:144-148.http://www.saludcolombia.com/actual/htmlnormas/Res412_00.htm.Wild JJ, Neal D. The use of high frequency ultrasonic waves for detecting changes of texture in living tisúes. Lancet 1951;1:655-657.Romero J, Aguirre D. BI-RADS en el informe ecográfico. Rev Col Radiol 2003;14(1):1325-1332.American College of Radiology. Standard for the perfomance of the breast US examination. Reston VA. ACR 2002.Smith DN. Breast Ultrasound. Radiol Clin N Am 2001;39:485-497. 154. Metha TS. Current uses of ultrasound in the evaluation of the breast. Radiol Clin N Am 2003;41:841-856.Gordon PB. Ultrasound for breast cancer screening and staging. Radiol Clin N Am 2002;40:431-441.Baker JA, Kornguth PJ, Soo MS, Walsk R y Mengoni P. Sonography of solid breast lesions: observer variability of lesion description and assessment. Am J Roentgenol 1999;172:1621-1625.Bosh AM, Kessels AGH et al. Interexamination variation of whole breast ultrasound. Br J Radiol 2003;328-331.Ikeda DM. Ecografía mamaria. En: Los Requisitos. Radiología de la mama. Edición en español. Ikeda DM Ed Elsevier Mosby Madrid; 2005 pp. 131-160.Hilton SW, Leopold GR, Olson LK, Wilson SA. Real-time breast Sonography; application in 300 consecutive patients. Am J Roentgenol 1984;147:479-486.Ciatto S, Cariaggi P, Bulgaresi P. The value of routine cytologic examination of breast cyst fluids. Acta Cytol 1987;31:301-304.Berg WA. Breast Ultrasonography: Cystic lesions and probable benign findings. In Women´s Imaging: categorical course syllabus. Leesburg VA. American Roentgen Ray Society 2004;95-101.Venta LA. Management of complex breast cysts. Am J Roentgenol 1999; 173: 1331-1336.Kolb TM, Lichy J, Newhouse JH. Occult cancer in women with dense breasts: detection with screening US—diagnostic yield and tumor characteristics. Radiology 1998;207:191-199.Palmer JR, Rosemberg L, Rao RS et al. Induced and spontaneous abortion in relation to risk of breast cancer (United States). Cancer Causes Control 1997;8:841-849.Berg WA. Cystic lesions of the breast: Sonographic- Pathologic correlation. Radiology 2003; 227: 183-191.Velasquez MV. Manejo de las lesiones quísticas complejas de seno. (Conferencia). Curso de Imágenes de la mujer. Fundación Santafé de Bogotá COL. 2003.Berg WA. Can clusters of microcyst appropriately be followed? (abstr). Radiology 2002;224:1375-1379.Mercado CL, Harmele-Bena D, Sinbger C et al. Papillary lesions of the breast: evaluation with stereotactic direccional vacuum-assisted biopsy. Radiology 2001;221:650-655.Stavros AT, Thickman D, Rapp CL, Dennos MA, Parker SH, Sisney GA. Solid breast nodules: use of Sonography to distinguish between benign and malignant lesions. Radiology 1995;196:123-134.Liberman L, Menell JH. BIRADS. Radiol Clin N Am 2002;40:409-430.Sickles EA. Probable benign breast lesions: when should follow-up be recommended and what is the optimal follow-up protocol?. Radiology 1999;213:11-14.Rahbar G, Sie AC, Hansen GC, Prince JS, Melany ML, Reynolds HE et al. Benign versus malignant solid breast masses: US differentiation. Radiology 1999;213:889-894.Dennis MA, Parker SH, Klauss AJ, Stavros AT et al. Breast Biopsy Avoidance: The Value of Normal Mammograms and Normal Sonograms in the Setting of a Palpable Lump. Radiology 2001; 219:186–191.Vignal P, Meslet MR, Romeo JM, Feuilhade F. Sonographic morphology of infiltrating breast carcinoma J Ultrasound med 2002;21:531-538.Sickles EA, Herzog KA. Intramammary scar tissue: a mimic of the mammographic appearance of carcinoma. AJR 1980;135:349–352Sickles EA, Herzog KA. Mammography of the post-surgical breast. AJR 1981 ;136:585–588Homer MJ. Mammographic appearance of the breast after needle localization and biopsy. Breast 1985 ;2:26–31Dershaw DD, Shank B, Reisinger S. Mammographic findings after breast cancer treatment with local excision and definitive irradiation. Radiology 1987 ;164:455–461Brenner RJ, Pfaff JM. Mammographic features after conservation therapy for malignant breast disease: serial findings standardized by regression analysis. AJR 1996 ;167:171–178Brenner RJ, Pfaff JM. Mammographic changes after excisional breast biopsy for benign disease. AJR 1996;167:1047–1052Lamm RL, Jackman RJ. Mammographic abnormalities caused by percutaneus stereotactic biopsy of histologically benign lesions evident on follow –up mammograms. AJR 2000;174:753–756McDonald S, Saslow D and. Alciati MH. Performance and Reporting of Clinical Breast Examination: A Review of the Literature. CA Cancer J Clin 2004;54;345-361Stavros, A T. Breast Ultrasound, eds. Lippincott Williams & Wilkins, 2006: 1-15.World Cancer Report IARC. Stewart BW, Kleihues P, editors. 188-219. 2003Pardo C, Murillo R, Piñeros M, Castro MA. Casos nuevos de cáncer en el Instituto Nacional de Cancerología, Colombia, 2002. Rev Colomb Cancerol 2003; 7(3):4-19.ORIGINAL2006_Tesis_Pabon_Romero_Juan_Carlos.pdf2006_Tesis_Pabon_Romero_Juan_Carlos.pdfTesisapplication/pdf942264https://repository.unab.edu.co/bitstream/20.500.12749/1861/1/2006_Tesis_Pabon_Romero_Juan_Carlos.pdfde4750fcaee21b0b8ebc134230a3bf4cMD51open accessTHUMBNAIL2006_Tesis_Pabon_Romero_Juan_Carlos.pdf.jpg2006_Tesis_Pabon_Romero_Juan_Carlos.pdf.jpgIM Thumbnailimage/jpeg8924https://repository.unab.edu.co/bitstream/20.500.12749/1861/2/2006_Tesis_Pabon_Romero_Juan_Carlos.pdf.jpge0d075329ee1440bfade9df35e738d05MD52open access20.500.12749/1861oai:repository.unab.edu.co:20.500.12749/18612021-11-11 09:59:32.234open accessRepositorio Institucional \| Universidad Autónoma de Bucaramanga - UNABrepositorio@unab.edu.co

Hallazgos mamográficos y ecográficos de 10000 estudios realizados en el servicio de radiología de la Foscal entre enero de 1998 y Junio del 2004

Publicaciones similares